These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 8671895)

  • 1. Receptors for advance glycation end-products (AGE) - expression by endothelial cells in non-diabetic uraemic patients.
    Greten J; Kreis I; Wiesel K; Stier E; Schmidt AM; Stern DM; Ritz E; Waldherr R; Nawroth PP
    Nephrol Dial Transplant; 1996 May; 11(5):786-90. PubMed ID: 8671895
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression of receptors for advanced glycation end-products in occlusive vascular and renal disease.
    Bierhaus A; Ritz E; Nawroth PP
    Nephrol Dial Transplant; 1996; 11 Suppl 5():87-90. PubMed ID: 9044315
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Advanced glycation end products (AGEs) on the surface of diabetic erythrocytes bind to the vessel wall via a specific receptor inducing oxidant stress in the vasculature: a link between surface-associated AGEs and diabetic complications.
    Wautier JL; Wautier MP; Schmidt AM; Anderson GM; Hori O; Zoukourian C; Capron L; Chappey O; Yan SD; Brett J
    Proc Natl Acad Sci U S A; 1994 Aug; 91(16):7742-6. PubMed ID: 8052654
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Activation of receptor for advanced glycation end products: a mechanism for chronic vascular dysfunction in diabetic vasculopathy and atherosclerosis.
    Schmidt AM; Yan SD; Wautier JL; Stern D
    Circ Res; 1999 Mar; 84(5):489-97. PubMed ID: 10082470
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relationship between the expression of advanced glycation end-products (AGE) and the receptor for AGE (RAGE) mRNA in diabetic nephropathy.
    Suzuki D; Toyoda M; Yamamoto N; Miyauchi M; Katoh M; Kimura M; Maruyama M; Honma M; Umezono T; Yagame M
    Intern Med; 2006; 45(7):435-41. PubMed ID: 16679697
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The endothelial cell binding site for advanced glycation end products consists of a complex: an integral membrane protein and a lactoferrin-like polypeptide.
    Schmidt AM; Mora R; Cao R; Yan SD; Brett J; Ramakrishnan R; Tsang TC; Simionescu M; Stern D
    J Biol Chem; 1994 Apr; 269(13):9882-8. PubMed ID: 8144581
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Endothelial dysfunction in patients with chronic kidney disease results from advanced glycation end products (AGE)-mediated inhibition of endothelial nitric oxide synthase through RAGE activation.
    Linden E; Cai W; He JC; Xue C; Li Z; Winston J; Vlassara H; Uribarri J
    Clin J Am Soc Nephrol; 2008 May; 3(3):691-8. PubMed ID: 18256374
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Advanced glycation end products activate endothelium through signal-transduction receptor RAGE: a mechanism for amplification of inflammatory responses.
    Basta G; Lazzerini G; Massaro M; Simoncini T; Tanganelli P; Fu C; Kislinger T; Stern DM; Schmidt AM; De Caterina R
    Circulation; 2002 Feb; 105(7):816-22. PubMed ID: 11854121
    [TBL] [Abstract][Full Text] [Related]  

  • 9. RAGE: a novel cellular receptor for advanced glycation end products.
    Schmidt AM; Hori O; Cao R; Yan SD; Brett J; Wautier JL; Ogawa S; Kuwabara K; Matsumoto M; Stern D
    Diabetes; 1996 Jul; 45 Suppl 3():S77-80. PubMed ID: 8674899
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The biology of the receptor for advanced glycation end products and its ligands.
    Schmidt AM; Yan SD; Yan SF; Stern DM
    Biochim Biophys Acta; 2000 Dec; 1498(2-3):99-111. PubMed ID: 11108954
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Roles of the receptor for advanced glycation endproducts in diabetes-induced vascular injury.
    Yonekura H; Yamamoto Y; Sakurai S; Watanabe T; Yamamoto H
    J Pharmacol Sci; 2005 Mar; 97(3):305-11. PubMed ID: 15750291
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Receptor for advanced glycation end products (AGEs) has a central role in vessel wall interactions and gene activation in response to circulating AGE proteins.
    Schmidt AM; Hasu M; Popov D; Zhang JH; Chen J; Yan SD; Brett J; Cao R; Kuwabara K; Costache G
    Proc Natl Acad Sci U S A; 1994 Sep; 91(19):8807-11. PubMed ID: 8090728
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The receptor for advanced glycation end-products has a central role in mediating the effects of advanced glycation end-products on the development of vascular disease in diabetes mellitus.
    Hori O; Yan SD; Ogawa S; Kuwabara K; Matsumoto M; Stern D; Schmidt AM
    Nephrol Dial Transplant; 1996; 11 Suppl 5():13-6. PubMed ID: 9044300
    [TBL] [Abstract][Full Text] [Related]  

  • 14. RAGE expression in the human peritoneal membrane.
    Kihm LP; Wibisono D; Müller-Krebs S; Pfisterer F; Morath C; Gross ML; Morcos M; Seregin Y; Bierhaus A; Nawroth PP; Zeier M; Schwenger V
    Nephrol Dial Transplant; 2008 Oct; 23(10):3302-6. PubMed ID: 18477569
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inflammation and advanced glycation end products in uremia: simple coexistence, potentiation or causal relationship?
    Schwedler S; Schinzel R; Vaith P; Wanner C
    Kidney Int Suppl; 2001 Feb; 78():S32-6. PubMed ID: 11168979
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Involvement of the receptor for advanced glycation-end products (RAGE) in beta-amyloid-induced toxic effects in rat cerebromicrovascular endothelial cells cultured in vitro.
    Baiguera S; Fioravanzo L; Grandi C; Di Liddo R; Parnigotto PP; Folin M
    Int J Mol Med; 2009 Jul; 24(1):9-15. PubMed ID: 19513528
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Novel splice variants of the receptor for advanced glycation end-products expressed in human vascular endothelial cells and pericytes, and their putative roles in diabetes-induced vascular injury.
    Yonekura H; Yamamoto Y; Sakurai S; Petrova RG; Abedin MJ; Li H; Yasui K; Takeuchi M; Makita Z; Takasawa S; Okamoto H; Watanabe T; Yamamoto H
    Biochem J; 2003 Mar; 370(Pt 3):1097-109. PubMed ID: 12495433
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of receptors for advanced glycosylated end-products in renal disease.
    Abel M; Ritthaler U; Zhang Y; Deng Y; Schmidt AM; Greten J; Sernau T; Wahl P; Andrassy K; Ritz E
    Nephrol Dial Transplant; 1995; 10(9):1662-7. PubMed ID: 8559486
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Receptor for advanced glycation end products (RAGE)-expressing endothelial cells co-express AGE and S100 in human periapical granulomas.
    Takeichi O; Hatori K; Kamimoto A; Oka S; Ogiso B; Saito I
    J Dent; 2011 Oct; 39(10):679-85. PubMed ID: 21864645
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The AGE-RAGE system and diabetic nephropathy.
    Sakurai S; Yonekura H; Yamamoto Y; Watanabe T; Tanaka N; Li H; Rahman AK; Myint KM; Kim CH; Yamamoto H
    J Am Soc Nephrol; 2003 Aug; 14(8 Suppl 3):S259-63. PubMed ID: 12874443
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.